Document 8R60wbNkeD283bnvapaooBDg5

Message From: Sent: To: CC: Subject: Shoshana Wodinsky Ex. 6 3/27/2018 3:05:32 PM Daguillard, Robert [/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=bbe9682b940c4f2c90732e4d37355dd4-Daguillard,] Press [/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=b293283291dc44eOb5dlc36be9281d8a-Press] Re: Subject: MEDIA INQUIRY: Filtering pharmaceuticals out of wastewater Thank you, Robert. On Tue, Mar 27, 2018 at 11:04 AM, Daguillard, Robert <Daguillard.Robert@epa.gov> wrote: Shoshana, for attribution to "an EPA spokesperson," please: On Background: We can offer theses webinars for background information: Pharmaceutical Residues in Municipal Wastewater Concentrations of Prioritized Pharmaceuticals in Effluents from so Large Wastewater Treatment Plants in the US and Implications for Risk Estimation From: Lynn, Tricia Sent: Tuesday, March 20, 2018 3:54 PM To: Press <Press@epa.gov> Subject: FW: MEDIA INQUIRY: Filtering pharmaceuticals out of wastewater I'll work with OW. From: Shoshana Wodinsky i Sent: Tuesday, March 20, 20i8 3:11 PM To: Lynn, Tricia <1ynn.tricia@epa.gov> Ex. 6 Hello Tricia, My name is Shoshana -- I'm a reporter for Scienceline currently working on a story about water filtration -- specifically, why it's so difficult to remove pharmaceuticals from water. Sierra Club v. EPA 18cv3472 NDCA Tier 13 ED 002061 00018143-00001 Please let me know If you could possibly schedule a phone call this week or next, or if you'd prefer to keep the questions email only. If there are any other colleagues that you believe could speak to this issue, feel free to forward this email their way. Looking forward to hearing from you. All the best, SW Sierra Club v. EPA 18cv3472 NDCA Tier 13 ED 002061 00018143-00002